ENDRA Life Sciences Says On March 19 , Reduced Number Of Employees In Order To Reduce Cash Expenditures And Extend Its Operational Runway; Expects To Incur Pre-Tax Cash Charges Of ~$51,000 Associated With Severance Payments To Former Employees

Costs Associated with Exit or Disposal Activities.

On March 25, 2026, ENDRA Life Sciences Inc. (the "Company") announced that it has initiated a process to evaluate a range of strategic alternatives aimed at maximizing shareholder value. In connection with this revised strategy, on March 19, 2026, the Company reduced the number of its employees in order to reduce cash expenditures and extend its operational runway. As a result, the Company expects to incur pre-tax cash charges of approximately $51,000 associated with severance payments to former employees. While the Company will continue to pursue its TAEUS business, this charge reflects the change in strategic direction for the Company. The Company expects to recognize the severance charges in the first quarter of 2026.